Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Karen Frudd, Sobha Sivaprasad, Rajiv Raman, Subramanian Krishnakumar, Yeddula Rebecca Revathy & Patric Turowski. (2021) Diagnostic circulating biomarkers to detect vision‐threatening diabetic retinopathy: Potential screening tool of the future?. Acta Ophthalmologica 100:3.
Crossref
Crossref
Wentao Liang, Li Huang, Xiang Ma, Lijie Dong, Rui Cheng, Marcus Dehdarani, Dimitrios Karamichos & Jian-xing Ma. (2022) Pathogenic Role of Diabetes-Induced Overexpression of Kallistatin in Corneal Wound Healing Deficiency Through Inhibition of Canonical Wnt Signaling. Diabetes 71:4, pages 747-761.
Crossref
Crossref
Rahmeh Othman, Gael Cagnone, Jean-Sébastien Joyal, Elvire Vaucher & Réjean Couture. (2021) Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies. Cells 10:8, pages 1913.
Crossref
Crossref
Wai Han Yiu, Ye Li, Sarah W.Y. Lok, Kam Wa Chan, Loretta Y.Y. Chan, Joseph C.K. Leung, Kar Neng Lai, James H.L. Tsu, Julie ChaoXiao-Ru Huang, Hui Yao Lan & Sydney C.W. Tang. (2021) Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling. Clinical Science 135:3, pages 429-446.
Crossref
Crossref
Marcella Nebbioso, Alessandro Lambiase, Marta Armentano, Giosuè Tucciarone, Vincenza Bonfiglio, Rocco Plateroti & Ludovico Alisi. (2020) The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies. Antioxidants 9:8, pages 666.
Crossref
Crossref
Yanhui Yang, Xuemin He, Rui Cheng, Qian Chen, Chunyan Shan, Liming Chen & Jian‐xing Ma. (2020) Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation. The FASEB Journal 34:6, pages 8428-8441.
Crossref
Crossref
Fauziyya Muhammad, Priscilla N. Avalos, M. H. Mursalin, Jian-Xing Ma, Michelle C. Callegan & Darren J. Lee. (2020) Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells. Frontiers in Immunology 11.
Crossref
Crossref
Julie Chao, Youming Guo & Lee Chao. (2018) Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity 2018, pages 1-8.
Crossref
Crossref
Gema Frühbeck, Javier Gómez-Ambrosi, Amaia Rodríguez, Beatriz Ramírez, Víctor Valentí, Rafael Moncada, Sara Becerril, Xabier Unamuno, Camilo Silva, Javier Salvador & Victoria Catalán. (2018) Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress. Metabolism 87, pages 123-135.
Crossref
Crossref
Julie Chao, Pengfei Li & Lee Chao. 2017. Sepsis. Sepsis.
Youming Guo, Pengfei Li, Lin Gao, Jingmei Zhang, Zhirong Yang, Grant Bledsoe, Eugene Chang, Lee Chao & Julie Chao. (2017) Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell 16:4, pages 837-846.
Crossref
Crossref
Julie ChaoGrant BledsoeLee Chao. (2016) Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension 68:3, pages 533-541.
Crossref
Crossref
Jiaze Li, Smriti Krishna & Jonathan Golledge. (2016) The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm. International Journal of Molecular Sciences 17:8, pages 1312.
Crossref
Crossref
Teena Bhakuni, Mohammad Farhan Ali, Irshad Ahmad, Shadabi Bano, Shoyab Ansari & Mohamad Aman Jairajpuri. (2016) Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay. Archives of Biochemistry and Biophysics 604, pages 128-142.
Crossref
Crossref
Mohamed A El-Asrar, Nevine G Andrawes, Eman A Ismail & Shaimaa MH Salem. (2015) Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness. Vascular Medicine 20:6, pages 509-517.
Crossref
Crossref
Rui Cheng & Jian-xing Ma. (2015) Angiogenesis in diabetes and obesity. Reviews in Endocrine and Metabolic Disorders 16:1, pages 67-75.
Crossref
Crossref
Ling Zhao, Sherrina H. Patel, Jacqueline Pei & Kang Zhang. (2013) Antagonizing Wnt Pathway in Diabetic Retinopathy. Diabetes 62:12, pages 3993-3995.
Crossref
Crossref
Xiaochen Liu, Bin Zhang, Jeffrey D. McBride, Kevin Zhou, Kyungwon Lee, Yueping Zhou, Zuguo Liu & Jian-xing Ma. (2013) Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway. Diabetes 62:12, pages 4228-4238.
Crossref
Crossref
Yachao Yao, Lei Li, Xuan Huang, Xiaoqiong Gu, Zumin Xu, Yang Zhang, Lijun Huang, Shuai Li, Zhiyu Dai, Cen Li, Ti Zhou, Weibin Cai, Zhonghan Yang, Guoquan Gao & Xia Yang. (2013) SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway. FEBS Journal 280:14, pages 3244-3255.
Crossref
Crossref
Haidong Zhu, Julie Chao, Ishita Kotak, Dehuang Guo, Samip J. Parikh, Jigar Bhagatwala, Yutong Dong, Sagar Y. Patel, Chris Houk, Lee Chao & Yanbin Dong. (2013) Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents. Metabolism 62:5, pages 642-646.
Crossref
Crossref
Takeshi Kita & Edward P. Feener. 2011. Kinins. Kinins
171
186
.
Edward P. Feener. (2010) Plasma Kallikrein and Diabetic Macular Edema. Current Diabetes Reports 10:4, pages 270-275.
Crossref
Crossref
Bin Zhang, Jose G. Abreu, Kevin Zhou, Ying Chen, Yang Hu, Ti Zhou, Xi He & Jian-xing Ma. (2010) Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proceedings of the National Academy of Sciences 107:15, pages 6900-6905.
Crossref
Crossref
Kyunggon Kim, Sang Jin Kim, Hyeong Gon Yu, Jiyoung Yu, Kyong Soo Park, In-Jin Jang & Youngsoo Kim. (2009) Verification of Biomarkers for Diabetic Retinopathy by Multiple Reaction Monitoring. Journal of Proteome Research 9:2, pages 689-699.
Crossref
Crossref
Bo Shen, Robert S. SmithJr.Jr., Yi-Te Hsu, Lee Chao & Julie Chao. (2009) Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression. Journal of Biological Chemistry 284:51, pages 35471-35478.
Crossref
Crossref
Noriaki Kato, Yunlong Hou, Zhenhui Lu, Chunmei Lu, Hiroshi Nagano, Kiyoshi Suzuma, Hitoshi Takagi & Yukiharu Matsumoto. (2009) Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: Potential roles of vascular endothelial growth factor and nitric oxide. European Journal of Pharmacology 606:1-3, pages 187-190.
Crossref
Crossref
Thomas W Gardner & David A Antonetti. (2007) A prize catch for diabetic retinopathy. Nature Medicine 13:2, pages 131-132.
Crossref
Crossref
Sarah X. Zhang & Jian-xing Ma. (2007) Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Progress in Retinal and Eye Research 26:1, pages 1-37.
Crossref
Crossref
Jian-Zing Ma & Sarah X. Zhang. 2006. Ocular Angiogenesis. Ocular Angiogenesis
23
44
.
Robert Q. Miao, Vincent Chen, Lee Chao & Julie Chao. (2003) Structural elements of kallistatin required for inhibition of angiogenesis. American Journal of Physiology-Cell Physiology 284:6, pages C1604-C1613.
Crossref
Crossref
G. Gao*C. Shao*S. X. Zhang, A. Dudley, J. Fant & J.-X. Ma. (2003) Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia 46:5, pages 689-698.
Crossref
Crossref
Robert Q. MiaoJun AgataLee ChaoJulie Chao. (2002) Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100:9, pages 3245-3252.
Crossref
Crossref
Michelle Kurpakus-Wheater, Karen A. Kernacki & Linda D. Hazlett. (2001) Maintaining Corneal Integrity How the “Window” Stays Clear. Progress in Histochemistry and Cytochemistry 36:3, pages 179-259.
Crossref
Crossref
Heather C. Hatcher, Nancy M. Wright, Julie Chao, Lee Chao & Jian‐Xing Ma. (1999) Kallikrein‐binding protein is induced by growth hormone in the dwarf rat. The FASEB Journal 13:13, pages 1839-1844.
Crossref
Crossref